Table 2.
Lymphocyte levels of patients with Gaucher, MPS and Pompe diseases.
| Lymphocytes | Gaucher disease N = 21 | MPS N = 36 | Pompe disease N = 8 | p | |
|---|---|---|---|---|---|
| Total lymphocytes × 109/L | Median (range) | 2700(1300–6800) | 3900(1600–7700) | 4100(1400–6900) | 0.156 |
| T cells (CD3+) cells/μL | Median(range) | 67.4(60.1–83.6) | 70.9(55.8–92) | 73.7(62.6–78.4) | 0.173 |
| T CD4+ (CD3+CD4+) cells/μL | Median(range) | 40(27.2–54.8) | 38.4(11.9–53.8) | 43.3(33.5–55.7) | 0.946 |
| T CD8+ (CD3+CD8+) cells/μL | Median(range) | 25,1(20–42.8) | 24.8(7.1–52) | 22.8(5.9–39) | 0.426 |
| B cells (CD19+) cells/μL | Median(range) | 17.5(8.5–27.8) | 17.5(8.5–27.8) | 18.5(10.1–29.4) | 0.319 |
| NK cells (CD3+/CD16+/CD56+) cells/μL | Median(range) | 10.5(2.7–24) | 8.5(2.8–30.7) | 8.45(5.7–13) | 0.238 |
| HLA-DR cells/μL | Median(range) | 25.2(12.2–45.9) | 25.3(10–55) | 25.1(14.8–32.8) | 0.553 |
MPS: mucopolysaccharidosis; NK: natural killer; HLA-DR: human leukocyte antigen–DR isotype; statistically significant at p < 0.05.